REDLANDS, Calif. and AUSTIN, Texas, Sept. 26, 2018 /PRNewswire/ — Renovis Surgical Technologies, Inc. today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market the Tesera® X Lateral Interbody Fusion System. Tesera X is the latest product to utilize Renovis’ proprietary 3D-printed porous architecture, which is made using additively manufactured titanium alloy, and […]